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OBJECTIVES: Several studies found a significant association between earlobe crease (ELC) and cardiovascu-
lar disease (CVD). Metabolic syndrome (MS) is a group of high-risk factors that are a collection of cardiovas-
cular risk factors. Scant data are available about the relationship between ELC and MS. The purpose of the cur-
rent study was to examine the correlation between ELC and MS.
METHODS: A cross-sectional study was performed on 3,835 subjects (1,672 females, 43.6%) aged 20 to 79 
years who visited a health promotion center. To increase the reliability of the diagnosis of MS, both the modi-
fied Na tional Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and International Dia-
betes Federation (IDF) criteria were applied. Independent association between ELC and MS was assessed us-
ing multiple logistic regression analysis after adjusting for confounding variables.
RESULTS: The frequency of ELC was 20.89% and the prevalence of MS was 11.03% (NCEP criteria) and 9.75% 
(IDF criteria). The prevalence of both ELC and MS significantly increased with age. The modified Framingham 
risk score was significantly higher in subjects with ELC than without. After adjusting for conventional risk fac-
tors for CVD, the risk of MS increased significantly in the presence of ELC.
CONCLUSION: The current study showed that the odds ratio for MS increased in the presence of ELC in Ko-
rean adults. ELC is an auxiliary indicator of MS, although prognostic value might be limited. Further studies 
are warranted to elucidate the clinical significance of ELC.
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INTRODUCTION
Diagonal earlobe crease (ELC) (Figure 1) is a diagonal wrinkle 
or deep furrow that extends from the external part of the exter-
nal acoustic meatus to the bottom edge of the earlobe [1,2]. 
A relationship between the presence of ELC and cardiovas-
cular disease (CVD)was first reported by Frank et al. [3]. There-
after, several clinical studies, including autopsy-based [4] and 
histopathological examinations [5], confirmed that ELC is cor-
related with CVD [6,7]. In Korea, Park et al. [8] reported that 
ELC was an independent risk factor for hemorrhagic stroke. 
Celik and colleagues [9] found that ELC was correlated with 
carotid intima-media thickness (IMT), which has recently been 
used in the diagnosis of systemic atherosclerosis. These latter 
studies support the hypothesis that ELC was related with CVD.
It is widely known that metabolic syndrome (MS) is a global 
cardiometabolic risk factor for CVD [10]. It has also been shown 
that MS occurs due to accumulated risk factors for developing 
atherosclerosis [11-13]. For several years, MS has been regard-
ed as a disease entity with well-known risk factors for develop-
ing CVD including hypertension, high low-density lipoprotein 
(LDL)-cholesterolemia, low high-density lipoprotein (HDL)-
cholesterolemia, hyperglycemia, obesity, physical inactivity, and 
blood coagulation disorder [14], which are commonly found in 
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modern society.
Although CVD, ELC, and MS might have a common patho-
physiology such as atherosclerosis or vascular changes, no stud-
ies have reported a correlation between ELC and MS. We per-
formed a cross-sectional study of a sample of the Korean popu-
lation to evaluate the relationship between ELC and MS.
MATERIALS AND METHODS
Study subjects
This study was conducted on a total of 4,243 subjects (1,868 
females, 2,375 males) aged between 20-79 years old who had 
received a standard health check-up at the Health Promotion 
Center of Severance Hospital between October 2007 and March 
2008. ELC was defined as a diagonal wrinkle or deep furrow 
extending from the external part of the external acoustic me-
atus to the earlobe without a discontinuity. Unilateral and bilat-
eral ELC were both considered to be ELC positive. ELC was 
measured by the same observer. Of the total subjects, 219 who 
had pierced ears (n=142) or showed an incomplete pattern of 
ELC (n=77) in whom a diagnosis of ELC might be confused, 
were excluded from analysis. Subjects with pre-existing CVD 
(n=189) including myocardial infarction, angina pectoris, stroke, 
transient ischaemic attack, carotid endarterectomy, and periph-
eral arterial occlusive disease, were also excluded, leaving 3,835 
subjects that were enrolled in the study. The study was approv-
ed by the Institutional Review Board at Severance Hospital, Yon-
sei University College of Medicine in Seoul, Korea.
Assessment of cardiovascular risk factors
In addition to medical history, personal history of smoking 
and family history of premature coronary artery disease (CAD) 
were examined in an interview. To increase the reliability of di-
agnostic criteria for MS, both the modified National Cholesterol 
Education Program Adult Treatment Panel III (NCEP ATP III) 
[15] and and International Diabetes Federation (IDF) definitions 
[16] were applied. Waist circumference was measured based on 
criteria for determining abdominal obesity in Koreans (males, 
≥90 cm; females, ≥85 cm) [17]. The Framingham risk score 
(FRS), a differential scoring system based on the modified NCEP 
ATP III from 2002, was used to assess age, smoking, total cho-
lesterol, HDL cholesterol, hypertension, and sex [10].
Assessment of anthropometric and laboratory factors
Height and weight were measured without shoes in light in-
door clothing to the nearest 0.1 cm and 0.1 kg, respectively. 
Body mass index (BMI) was calculated by dividing weight (kg) 
by the square of height (m2). In accordance with the guidelines 
of the National Institutes of Health (NIH), waist circumference 
was measured to the nearest 0.1 cm on a horizontal plane to 
the level directly above the iliac crest in an upright position. 
Blood pressure was measured using an automatic blood pres-
sure monitor (ROLL STAND MMS-2000R, Mediana Co., Seoul, 
Korea) after a five-minute stabilisation. Subjects were not al-
lowed to drink coffee or smoke cigarettes within 30 minutes 
following blood pressure monitoring. A sample of fasting ve-
nous blood was taken for the measurement of glucose, total 
cholesterol, HDL cholesterol, LDL cholesterol, and triglyceride. 
For venous blood samples, serum biochemical parameters were 
measured after a ten-hour fast. The blood samples were anal-
ysed using an automated chemistry analyzer (Hitachi 7600, Hi-
tachi High-Technologies Co., Tokyo, Japan).
Statistical analysis
To examine the distribution of statistical data, all continuous 
variables were expressed as mean and standard deviation (SD). 
Chi-square test was used for comparison of ELC, sex, past his-
tory of disease, and family history. Intergroup comparison of 
cardiovascular risk factors such as age, blood pressure, fasting 
blood sugar and BMI was made using 2-sample t-test. Follow-
ing adjustment for cardiovascular risk factors including age, mul-
tiple logistic regression analysis was used to evaluate the effect 
of ELC on MS. The correlation between cardiovascular risk fac-
tors that had multicollinearity was also examined. Furthermore, 
to assess the significance of various models formed by various 
combinations, a likelihood ratio test and the Hosmer-Lemeshow 
test were performed. A p-value of <0.05 was considered statis-
Figure 1. Typical shape of earlobe crease.
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Table 1. Baseline characteristics depending on MS (modified NCEP ATP III criteria)
MS (+)
(n=423)
MS (-)
(n=3,412)
Total
(n=3,835) p-value
Earlobe crease (yes) 205 (48.46) 596 (17.47) 801 (20.89) <0.001
Age (yr) 53.28±10.99 47.86±11.53 48.46±11.60 <0.001
Male gender 278 (65.96) 1884 (55.22) 2163 (56.3) <0.001
Body mass index (kg/m2) 26.83±3.03 23.42±2.91 23.80±3.11 <0.001
Waist circumference (cm) 90.54±7.64 79.52±8.59 80.73±9.17 <0.001
Current smoker (yes) 205 (48.46) 1304 (38.22) 1509 (39.35) <0.001
Smoking status (pack year) 12.35±16.22 8.36±12.95 8.80±13.41 <0.001
SBP (mmHg) 128.56±13.47 115.78±13.07 117.19±13.71 <0.001
DBP (mmHg) 83.76±9.65 74.18±10.47 75.23±10.80 <0.001
Total cholesterol (mg/dL) 203.78±38.37 196.25±34.53 197.08±35.05 <0.001
Triglyceride (mg/dL) 222.09±85.89 125.41±67.04 136.08±75.69 <0.001
HDL cholesterol (mg/dL) 43.60±9.96 56.73±13.08 55.29±13.42 <0.001
LDL cholesterol (mg/dL) 122.49±30.86 118.74±29.29 119.15±29.49 0.014
<0.05
Fasting glucose (mg/dL) 103.35±28.12 91.11±16.82 92.46±18.80 <0.001
Uric acid (mg/dL) 5.52±1.37 4.94±1.44 5.00±1.44 <0.001
Antihypertensive drug use (yes) 144 (34.04) 295 (8.65) 439 (11.45) <0.001
Antihyperglycaemic drug use (yes) 60 (14.18) 65 (1.91) 125 (3.26) <0.001
Antilipidaemic drug use (yes) 50 (11.82) 67 (1.96) 117 (3.05) <0.001
Family history of premature CAD (yes) 33 (7.80) 262 (7.68) 295 (7.69) 0.929
Values are presented as number (%) or mean±standard deviation.
MS, metabolic syndrome; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CAD, coro-
nary artery disease.
Table 2. The prevalence of metabolic syndrome depends on age
Age (yr) NCEP ATP III (%) IDF (%)
20-29 1.73 1.73
30-39 6.5 6.35
40-49 9.82 9.91
50-59 11.53 10.36
60-69 17.69 12.96
70-79 20.47 17.32
Total 10.71 9.59
NCEP ATP III, National Cholesterol Education Program Adult Treatment Pa-
nel III; IDF, International Diabetes Federation.
Table 3. The prevalence of ELC depends on age
Age (yr) Male (%) Female (%)
20-29 9.71 4.69
30-39 13.81 4.26
40-49 22.13 9.52
50-59 31.65 16.84
60-69 42.76 27.12
70-79 44.12 37.29
Total 26.49 13.64
ELC, earlobe crease.
tically significant. All statistical analyses were performed using 
SAS version 9.1 (SAS Inc., Cary, NC, USA).
RESULTS
Baseline characteristics of the subjects
Baseline characteristics and assessment categories of 3,835 
subjects (1,672 females, 43.60%) enrolled in the current study 
are summarised in Table 1. Except for a family history of CAD, 
all categories showed a significant difference depending on a 
MS diagnosis.
Prevalence of MS and ELC in each age group
Of the 3,835 subjects, 11.03% were diagnosed with MS, ac-
cording to the modified NCEP ATP III criteria. According to the 
IDF criteria, this figure was 9.75%. There was no significant dif-
ference in the prevalence of MS between the two criteria. Table 
2 shows that the prevalence of MS significantly increased with 
age under both classifications (p<0.001).
Of the 3,835 subjects, 801 (20.89%) had ELC. Table 3 shows 
that the frequency of ELC increased with age (p<0.001). In par-
ticular, the frequency of ELC was significantly higher in males 
than females (p<0.001).
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Correlation between ELC and FRS
To test for a correlation between ELC and the modified FRS, 
the FRS was analysed according to a three-grade classification 
based on the percentile value of ten-year risk (Table 4). The pre-
sences of ELC in both male and female subjects showed a sig-
nificant correspondence (p<0.001) to a higher FRS category.
Independent relationship between ELC and MS
As shown in Table 5, the odds ratio (OR) for MS was relative-
ly higher in the presence of ELC in both the modified NCEP 
ATP III and IDF criteria. The current study shows that the OR 
for MS was higher when subjects had ELC, after adjusting for 
age (Model 1). After adjusting for well-known major risk fac-
tors for CVD, including age (males, >45 yr; females, >55 yr), 
hypertension, smoking, obesity, dyslipidemia, diabetes mellitus, 
and a family history of premature CAD (Model 2), the risk for 
developing MS significantly increased in the presence of ELC 
for both criteria. Even after adjusting for the risk factors of cor-
onary artery diseases defined by the NCEP ATP III (Model 3), 
the OR for males was 1.81-2.17 and the OR for females was 
2.42-2.97.
DISCUSSION
The current study shows that the presence of ELC is signifi-
cantly associated with MS, independent of conventional CVD 
risk factors, in Korean adults without CVD. Subjects with ELC 
showed higher FRS than subjects without ELC.
The prevalence of ELC increased depending on age. Several 
studies have assumed that ELC and CVD were both part of the 
aging process [6,18]. In the present study, ELC was independen-
tly associated with MS after adjusting for age, and so it might 
be rash to regard ELC as a mere coincidence of the aging pro-
cess.
Our results confirmed that the presence of ELC was signifi-
cantly associated with MS independent of other confounding 
risk factors for MS. In the current study, the validity of each 
model and whether multicollinearity existed among variables 
were evaluated. A comparison of data explicability was made 
using a likelihood test between the models. This showed that 
Model 2 had the highest explicability. In Model 2, ELS was as-
sociated with MS after adjusting for age and other CVD risk 
factors in both sexes. 
The FRS is a score-based tool that is widely used to predict 
atherosclerotic CVD [19]. In the current study, the percentile 
Table 4. The modified FRS category depending on the presence of ELC in male and female subjects
FRS category (%) ELC (+) ELC (-) Total p-value
Male
Low (<10) 199 (36.85) 972 (59.71) 1,171 (54.01) <0.001*
Intermediate (10-19) 250 (36.30) 520 (31.94) 770 (35.52)
High (≥20) 91 (16.85) 136 (8.35) 227 (10.47)
Female
Low (<10) 209 (96.31) 1,442 (99.38) 1,651 (98.98) <0.001†
Intermediate (10-19) 7 (3.23) 9 (0.62) 16 (0.96)
High (≥20) 0 ( 1 (0.46) 1 (0.06)
Values are presented as number (%).
FRS, Framingham risk score; ELC, earlobe crease; *Chi-square test; †Fisher’s exact test.
Table 5. Independent association between ELC and MS after adjustment.
MS (NCEP ATP III) MS (IDF)
Male Female Male Female
Unadjusted 1.93 (1.68-2.22) 2.58 (2.12-3.13) 2.27 (1.98-2.62) 3.41 (2.74-4.26)
Model 1 1.88 (1.62-2.17) 2.05 (1.67-2.52) 2.27 (1.97-2.63) 2.85 (2.26-3.59)
Model 2 1.23 (1.01-1.50) 1.95 (1.38-2.78) 1.37 (1.13-1.66) 2.22 (1.60-3.08)
Model 3 1.81 (1.53-2.15) 2.42 (1.83-3.19) 2.17 (1.85-2.54) 2.97 (2.29-3.86)
Values are presented as OR (95% confidence interval).
Model 1: adjusted for age.
Model 2: adjusted for age, hypertension, smoking, obesity, dyslipidaemia, diabetes mellitus, family history of premature coronary artery disease.
Model 3: adjusted for age, hypertension, high-density lipoprotein cholesterol, family history of premature coronary artery disease.
ELC, earlobe crease; MS, metabolic syndrome; NCEP ATP III, National Cholesterol Education Program Adult Treatment Panel III; IDF, International Diabetes 
Federation.
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value of ten-year risk corresponding to the scores calculated in 
both males and females was analysed according to a three-grade 
classification and examined to determine whether it was corre-
lated with ELC. This analysis showed that there was a significant 
correlation for both males and females (p<0.001). The preva-
lence of ELC was higher in the low-risk group than in the high-
risk group of FRS category. This result might be caused by the 
low number of subjects enrolled in the high-risk group. The sub-
jects with a past history of CVD were excluded and only those 
of good health were enrolled in the current analysis, so the ac-
tual number in the high-risk group was much lower than in the 
low-risk group.
To date, several hypotheses have been proposed to explain 
the possible mechanism for the correlation between ELC and 
CVD. First, the earlobe and heart are supplied with blood flow 
via an end artery with no collateral circulation, and second, both 
ELC and CVD are caused by the systemic loss of elastin and 
elastic fiber [5,20,21]. Based on reports that ELC was indicative 
of the severity of atherosclerosis [22], it has been demonstrated 
to have a correlation with carotid IMT [23-25], which has re-
cently been used in the diagnosis of systemic atherosclerosis [9]. 
In the current study, ELC had a significant correlation with the 
FRS, which is an indicator for predicting CVD. Even after ad-
justing for factors that might affect CVD, the OR for MS was 
increased in the presence of ELC. This result suggests that ELC 
might be associated with MS in the subjects who did not have a 
CVD history. 
It should be noted that the present study has several limita-
tions. First of all no assessment of insulin resistance was concur-
rently made. The pathophysiology of MS is not clearly under-
stood, although it is well established that insulin resistance is a 
very important factor. The current study did not consider such 
objective indicators as homeostasis model assessment of insulin 
resistance (HOMA-IR) index or euglycemic-hyperinsulinemic 
clamp study, which can be used to measure insulin resistance. 
Hence, further studies are warranted to identify the correlation 
between ELC and insulin resistance. 
The recent understanding of the link between MS and athero-
sclerosis is that it may be more likely due to a chronic low-grade 
inflammatory status related to MS than to insulin resistance it-
self. The present study failed to include inflammatory markers 
such as hs-CRP. In future studies, the association between in-
flammatory markers and ELC should be assessed. 
No correlation between the length ratio of ELC to earlobe 
and MS was assessed. Additionally, the difference between uni-
lateral and bilateral ELC was not examined. Considering that 
no definite criteria for the length ratio of ELC to earlobe and 
those for the unilateral or bilateral presence of ELC have been 
established, we suggest that further studies are necessary to over-
come these limitations.
The current study had a cross-sectional design and a causal 
relationship could not be confirmed. Long-term cohort studies 
are required to inclusively evaluate the course of insulin resis-
tance, treatment response, and risk for developing CVD in MS 
patients who concurrently had ELC. 
FRS has a trend which overestimates the CVD risk in Kore-
ans, so this might affect the results. 
Interpretation of ELC was performed by only one observer, 
and so the results of the present study may be biased. 
CVD accounts for many deaths in Korea and around the world. 
Prediction and prevention of CVD are therefore significant fac-
tors in the clinical setting. In this regard, the current study is of 
great significance in that it identifies a correlation between MS, 
which is a group of high risk factors for CVD, and ELC. MS can 
confound the association between ELC and CAD, and so future 
studies of the ELC and CAD association should take into ac-
count the presence of MS.
CONFLICT OF INTEREST
The authors have no conflicts of interest to declare for this 
study. 
REFERENCES
1.	Shmilovich	H,	Cheng	VY,	Rajani	R,	Dey	D,	Tamarappoo	BK,	Naka-
zato	R,	et	al.	Relation	of	diagonal	ear	lobe	crease	to	the	presence,	ex-
tent,	and	severity	of	coronary	artery	disease	determined	by	coronary	
computed	tomography	angiography.	Am	J	Cardiol	2012;	109:	1283-
1287.	
2.	Choi	SI,	Kang	HC,	Kim	CO,	Lee	SB,	Hwang	WJ,	Kang	DR.	Rela-
tionship	between	earlobe	crease	and	brachial-ankle	pulse	wave	ve-
locity	in	non-hypertensive,	non-diabetic	adults	in	Korea.	Epidemiol	
Health	2009;	31:	e2009002.
3.	Frank	ST.	Aural	sign	of	coronary-artery	disease.	N	Engl	J	Med	1973;	
289:	327-328.
4.	Edston	E.	The	earlobe	crease,	coronary	artery	disease,	and	sudden	
cardiac	death:	an	autopsy	study	of	520	individuals.	Am	J	Forensic	
Med	Pathol	2006;	27:	129-133.
5.	Wermut	W,	Jaszczenko	S,	Ruszel	A.	Ear	lobe	crease	as	a	risk	factor	
in	coronary	disease.	Wiad	Lek	1980;	33:	435-438.	(Polish)
6.	Elliott	WJ.	Ear	lobe	crease	and	coronary	artery	disease.	1,000	pa-
tients	and	review	of	the	literature.	Am	J	Med	1983;	75:	1024-1032.
7.	Evrengül	H,	Dursunoğlu	D,	Kaftan	A,	Zoghi	M,	Tanriverdi	H,	Zun-
gur	M,	et	al.	Bilateral	diagonal	earlobe	crease	and	coronary	artery	
disease:	a	significant	association.	Dermatology	2004;	209:	271-275.
8.	Park	JK,	Kim	HJ,	Chang	SJ,	Koh	SB,	Koh	SY.	Risk	factors	for	hem-
orrhagic	stroke	in	Wonju,	Korea.	Yonsei	Med	J	1998;	39:	229-235.
9.	Celik	S,	Erdoğan	T,	Gedikli	O,	Kiriş	A,	Erem	C.	Diagonal	ear-lobe	
crease	is	associated	with	carotid	intima-media	thickness	in	subjects	
free	of	clinical	cardiovascular	disease.	Atherosclerosis	2007;	192:	
428-431.	
10.	National	Cholesterol	Education	Program	(NCEP)	Expert	Panel	on	
6Epidemiology and Health  2012;34:e2012004
Detection,	Evaluation,	and	Treatment	of	High	Blood	Cholesterol	in	
Adults	(Adult	Treatment	Panel	III).	Third	Report	of	the	National	Cho-
lesterol	Education	Program	(NCEP)	Expert	Panel	on	Detection,	Eval-
uation,	and	Treatment	of	High	Blood	Cholesterol	in	Adults	(Adult	
Treatment	Panel	III)	final	report.	Circulation	2002;	106:	3143-3421.
11.	Fruchart	JC,	Nierman	MC,	Stroes	ES,	Kastelein	JJ,	Duriez	P.	New	
risk	factors	for	atherosclerosis	and	patient	risk	assessment.	Circula-
tion	2004;	109:	III15-	III19.
12.	Kim	JA,	Montagnani	M,	Koh	KK,	Quon	MJ.	Reciprocal	relationships	
between	insulin	resistance	and	endothelial	dysfunction:	molecular	
and	pathophysiological	mechanisms.	Circulation	2006;	113:	1888-
1904.
13.	Semenkovich	CF.	Insulin	resistance	and	atherosclerosis.	J	Clin	Invest	
2006;	116:	1813-1822.
14.	Chobanian	AV,	Bakris	GL,	Black	HR,	Cushman	WC,	Green	LA,	Izzo	
JL	Jr,	et	al.	The	Seventh	Report	of	the	Joint	National	Committee	on	
Prevention,	Detection,	Evaluation,	and	Treatment	of	High	Blood	Pres-
sure:	the	JNC	7	report.	JAMA	2003;	289:	2560-2572.
15.	Grundy	SM,	Cleeman	JI,	Daniels	SR,	Donato	KA,	Eckel	RH,	Frank-
lin	BA,	et	al.	Diagnosis	and	management	of	the	metabolic	syndrome:	
an	American	Heart	Association/National	Heart,	Lung,	and	Blood	In-
stitute	scientific	statement:	Executive	Summary.	Crit	Pathw	Cardiol	
2005;	4:	198-203.
16.	International	Diabetes	Federation.	The	IDF	consensus	worldwide	
definition	of	the	metabolic	syndrome	[cited	2012	Jun	15].	Available	
from:	http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf.
17.	Lee	S,	Park	HS,	Kim	SM,	Kwon	HS,	Kim	DY,	Kim	DJ,	et	al.	Cut-
off	points	of	waist	circumference	for	defining	abdominal	obesity	in	
the	Korean	population.	Korean	J	Obes	2006;	15:	1-9.	(Korean)	
18.	Guţiu	I,	el	Rifai	C,	Mallozi	M.	Relation	between	diagonal	ear	lobe	
crease	and	ischemic	chronic	heart	disease	and	the	factors	of	coronary	
risk.	Med	Interne	1986;	24:	111-116.
19.	D’Agostino	RB	Sr,	Grundy	S,	Sullivan	LM,	Wilson	P;	CHD	Risk	
Prediction	Group.	Validation	of	the	Framingham	coronary	heart	dis-
ease	prediction	scores:	results	of	a	multiple	ethnic	groups	investiga-
tion.	JAMA	2001;	286:	180-187.	
20.	Kaukola	S.	The	diagonal	ear-lobe	crease,	a	physical	sign	associated	
with	coronary	heart	disease.	Acta	Med	Scand	Suppl	1978;	619:	1-49.
21.	Shoenfeld	Y,	Mor	R,	Weinberger	A,	Avidor	I,	Pinkhas	J.	Diagonal	
ear	lobe	crease	and	coronary	risk	factors.	J	Am	Geriatr	Soc	1980;	28:	
184-187.
22.	Tranchesi	Júnior	B,	Barbosa	V,	de	Albuquerque	CP,	Caramelli	B,	Ge-
bara	O,	Santos	Filho	RD,	et	al.	Diagonal	earlobe	crease	as	a	marker	
of	the	presence	and	extent	of	coronary	atherosclerosis.	Am	J	Cardiol	
1992;	70:	1417-1420.
23.	Celermajer	DS.	Noninvasive	detection	of	atherosclerosis.	N	Engl	J	
Med	1998;	339:	2014-2015.
24.	Davis	PH,	Dawson	JD,	Mahoney	LT,	Lauer	RM.	Increased	carotid	in-
timal-medial	thickness	and	coronary	calcification	are	related	in	young	
and	middle-aged	adults.	The	Muscatine	study.	Circulation	1999;	100:	
838-842.
25.	Davis	PH,	Dawson	JD,	Riley	WA,	Lauer	RM.	Carotid	intimal-medi-
al	thickness	is	related	to	cardiovascular	risk	factors	measured	from	
childhood	through	middle	age:	The	Muscatine	Study.	Circulation	
2001;	104:	2815-2819.
